Latest News and Press Releases

Fractyl Health Receives FDA Breakthrough Device Designation for Revita in Weight Maintenance for People with Obesity Who Discontinue GLP-1 Based Drugs

Fractyl Health to Present at Piper Sandler 2nd Annual Virtual Obesity Day

Fractyl Health Announces Advancement in Weight Maintenance Pipeline and Business Updates

Fractyl Health Presents New Preclinical Data on Sustained Weight Maintenance and Improved Body Composition from its Rejuva® Platform at ADA 2024.

Fractyl Health to Present New Preclinical Obesity Data from Rejuva® Platform at the American Diabetes Association’s 84th Scientific Sessions

Fractyl Health Presents Compelling Preclinical Data from Single-Administration GLP-1 Pancreatic Gene Therapy Rejuva® at Digestive Disease Week 2024

Fractyl Health Reports First Quarter 2024 Financial Results and Provides Business Updates

FRACTYL HEALTH PRESENTS CLINICAL UPDATE ON REVITA® GERMAN REAL- WORLD REGISTRY FOR PATIENTS WITH ADVANCED TYPE 2 DIABETES (T2D)

Fractyl Health to Present at BofA Securities 2024 Health Care Conference

Fractyl Health to Report First Quarter 2024 Financial Results and Provide Business Updates on May 13, 2024